This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Community Health's (CYH) Q4 Earnings Surpass, Improve Y/Y
by Zacks Equity Research
Community Health's (CYH) fourth-quarter earnings gain from lower costs. However, the same is offset to some extent by soft admissions.
4 Hospital Stocks to Gain From Growth in Patient Admissions
by Sapna Bagaria
Players in the hospital industry are likely to gain from increasing patient admissions, government grants and cost-control measures.
Molina Healthcare (MOH) Posts Q4 Loss, Misses on Revenues
by Zacks Equity Research
Molina Healthcare's (MOH) fourth-quarter results reflect escalating expenses.
Tenet Healthcare (THC) Q4 Earnings Beat Estimates, Rise Y/Y
by Zacks Equity Research
Tenet Healthcare's (THC) Q4 earnings improve on the back of better revenues.
Centene (CNC) Q4 Earnings Surpass Estimates, Tumble Y/Y
by Zacks Equity Research
Centene (CNC) Q4 results gain from improved revenues as well as better membership.
The Zacks Analyst Blog Highlights: Sony, Mondelez International, Twilio, Workday and HCA Healthcare
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Sony, Mondelez International, Twilio, Workday and HCA Healthcare
Q4 Earnings Scorecard and Analyst Reports for Sony, Mondelez & Twilio
by Sheraz Mian
We have provided a real-time update on the Q4 earnings season, in addition to featuring new research reports on 16 major stocks in today's Research Daily.
Ensign Group's (ENSG) Q4 Earnings Top Estimates, Improve Y/Y
by Zacks Equity Research
Ensign Group's (ENSG) fourth-quarter results reflect a year-over-year rise in revenues.
Humana's (HUM) Q4 Loss Narrower Than Expected, Tumble Y/Y
by Zacks Equity Research
Humana's (HUM) fourth-quarter results reflect elevated costs related to COVID-19 along with high marketing expenses.
HCA Healthcare's (HCA) Q4 Earnings Beat Estimates, Rise Y/Y
by Zacks Equity Research
HCA Healthcare's (HCA) fourth-quarter earnings gain on the back of better revenues.
HCA Holdings (HCA) Q4 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
HCA (HCA) delivered earnings and revenue surprises of 13.77% and 2.46%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?
What's in the Cards for HCA Healthcare (HCA) Q4 Earnings?
by Zacks Equity Research
HCA Healthcare's (HCA) fourth-quarter earnings are likely to have witnessed better patient volumes and improved revenues.
HCA Healthcare (HCA) Steps Up Efforts to Boost PPE Output
by Zacks Equity Research
HCA Healthcare (HCA) invests in new business to meet the buoyancy in demand for PPE and surgical masks.
Community Health (CYH) Unit Announces Junior Note Offerings
by Zacks Equity Research
Community Health's (CYH) wholly-owned arm exhibits monetary discretion by issuing notes to procure funds.
Here's Why You Should Hold MEDNAX (MD) in Your Portfolio Now
by Zacks Equity Research
Riding high on its strategic efforts and cost-cutting measures, MEDNAX (MD) holds enough potential to reap benefits for investors.
4 Sector ETFs & Stocks Top Despite Soft December Jobs Data
by Sanghamitra Saha
The U.S. jobs report for the month of December came in weaker than expected.
Here's Why You Should Bet on Acadia Healthcare (ACHC) Stock
by Zacks Equity Research
Acadia Healthcare (ACHC) has been benefiting from growing demand for behavioral health services, high revenues and solid cash flows.
Here's Why You Should Hold on to Universal Health (UHS) Now
by Zacks Equity Research
Rising high on solid segments and solvency levels, Universal Health (UHS) holds potential to reap benefits for investors.
Why Should You Retain HCA Healthcare (HCA) in Your Portfolio?
by Zacks Equity Research
Riding high on its growth efforts and cost-curbing initiatives, HCA Healthcare (HCA) holds potential to reap benefits for investors.
Enforcement of Price Transparency Rules Puts Hospitals in a Fix
by Zacks Equity Research
Hospital companies might feel the heat from price transparency rules, effective Jan 1, 2021.
Acadia Healthcare (ACHC) to Sell UK Unit to Focus on US Business
by Zacks Equity Research
Acadia Healthcare (ACHC) to divest its U.K. business to Waterland for concentrating on its mental health business in the United States.
Here's Why Community Health (CYH) Stock is an Attractive Bet Now
by Zacks Equity Research
Community Health (CYH) remains well-poised for growth on the back of constant efforts to streamline operations and reduced operating costs.
Molina Healthcare (MOH) Up 52.5% in a Year: More Room to Run?
by Zacks Equity Research
Molina Healthcare's (MOH) strategic initiatives augur well for its revenues, which in turn, might appreciate its stock price.
Tenet Healthcare (THC) Up 126.9% in 6 Months: More Room for Rally?
by Zacks Equity Research
Tenet Healthcare's (THC) strategic measures and cost-controlling efforts are expected to drive its margins, which in turn, might inflate its share price.
Tenet Healthcare (THC) to Rejig Business by Selling Urgent Care
by Zacks Equity Research
Tenet Healthcare (THC) to restructure its ambulatory care business by axing the urgent care business and focusing on growing the ambulatory surgery business.